MetaADEDB 2.0 @ LMMD
Glyxambi
(POMOOZUJAXCEKG-QPVQWCQSSA-N)
Structure
SMILES
CO[C@H]1O[C@@H](c2ccc(c(c2)Cc2ccc(cc2)O[C@@H]2COCC2)Cl)[C@@H]([C@H]([C@@H]1O)O)O.CC#CCn1c(nc2c1c(=O)n(Cc1nc(C)c3c(n1)cccc3)c(=O)n2C)N1CCC[C@H](C1)N
Molecular Formula:
C48H55ClN8O9
Molecular Weight:
923.452
Log P:
4.1377
Hydrogen Bond Acceptor:
17
Hydrogen Bond Donor:
4
TPSA:
214.47
CAS Number(s):
N/A
Synonym(s)
1.
Glyxambi
External Link(s)
PubChem Compound85364159
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Diabetic KetoacidosisFAERS: 37US FAERS
2Weight decreasedFAERS: 21US FAERS
3Blood glucose increasedFAERS: 20US FAERS
4DehydrationFAERS: 18US FAERS
5NauseaFAERS: 17US FAERS
6Urinary tract infectionFAERS: 15US FAERS
7PancreatitisFAERS: 14US FAERS
8DizzinessFAERS: 13US FAERS
9PruritusFAERS: 10US FAERS
10VomitingFAERS: 10US FAERS
11HeadacheFAERS: 9US FAERS
12Drug ineffectiveFAERS: 8US FAERS
13Abdominal PainFAERS: 7US FAERS
14ConstipationFAERS: 7US FAERS
15MyalgiaFAERS: 7US FAERS
16Vulvovaginal mycotic infectionFAERS: 7US FAERS
17KetoacidosisFAERS: 6US FAERS
18Unevaluable eventFAERS: 6US FAERS
19AlopeciaFAERS: 5US FAERS
20Blood glucose abnormalFAERS: 5US FAERS
21Cerebrovascular accidentFAERS: 5US FAERS
22FatigueFAERS: 5US FAERS
23Genital infection fungalFAERS: 5US FAERS
24MalaiseFAERS: 5US FAERS
25Myocardial InfarctionFAERS: 5US FAERS
26UrticariaFAERS: 5US FAERS
27AmnesiaFAERS: 4US FAERS
28AstheniaFAERS: 4US FAERS
29DysuriaFAERS: 4US FAERS
30Euglycaemic diabetic ketoacidosisFAERS: 4US FAERS
31PainFAERS: 4US FAERS
32PneumoniaFAERS: 4US FAERS
33AcidosisFAERS: 3US FAERS
34Blood creatinine increasedFAERS: 3US FAERS
35Blood glucose decreasedFAERS: 3US FAERS
36Blood glucose fluctuationFAERS: 3US FAERS
37Blood urine presentFAERS: 3US FAERS
38Diabetes mellitus inadequate controlFAERS: 3US FAERS
39Feeling abnormalFAERS: 3US FAERS
40HypersensitivityFAERS: 3US FAERS
41InfluenzaFAERS: 3US FAERS
42Medication ErrorFAERS: 3US FAERS
43Metabolic acidosisFAERS: 3US FAERS
44Musculoskeletal PainFAERS: 3US FAERS
45No adverse eventFAERS: 3US FAERS
46Oropharyngeal painFAERS: 3US FAERS
47PalpitationsFAERS: 3US FAERS
48SomnolenceFAERS: 3US FAERS
49SwellingFAERS: 3US FAERS
50Accidental overdoseFAERS: 2US FAERS
51Back PainFAERS: 2US FAERS
52BalanoposthitisFAERS: 2US FAERS
53Bowel movement irregularityFAERS: 2US FAERS
54Burning sensationFAERS: 2US FAERS
55ChillsFAERS: 2US FAERS
56CholelithiasisFAERS: 2US FAERS
57DysphoniaFAERS: 2US FAERS
58EpistaxisFAERS: 2US FAERS
59Erectile dysfunctionFAERS: 2US FAERS
60Food cravingFAERS: 2US FAERS
61Genital infectionFAERS: 2US FAERS
62HypophagiaFAERS: 2US FAERS
63Intestinal ObstructionFAERS: 2US FAERS
64Lip swellingFAERS: 2US FAERS
65NasopharyngitisFAERS: 2US FAERS
66NephrolithiasisFAERS: 2US FAERS
67Therapeutic response unexpectedFAERS: 2US FAERS
68ThirstFAERS: 2US FAERS
69Urinary tract infection fungalFAERS: 2US FAERS
70Acute kidney injuryFAERS: 1US FAERS
71Acute psychosisFAERS: 1US FAERS
72Adverse eventFAERS: 1US FAERS
73Alanine Aminotransferase IncreasedFAERS: 1US FAERS
74AngioedemaFAERS: 1US FAERS
75Aspartate Aminotransferase IncreasedFAERS: 1US FAERS
76Atrial FibrillationFAERS: 1US FAERS
77BlindnessFAERS: 1US FAERS
78Blood GlucoseFAERS: 1US FAERS
79Blood creatinine abnormalFAERS: 1US FAERS
80Blood insulin decreasedFAERS: 1US FAERS
81Blood ketone body increasedFAERS: 1US FAERS
82Blood potassium increasedFAERS: 1US FAERS
83Blood sodium decreasedFAERS: 1US FAERS
84Blood thyroid stimulating hormone increasedFAERS: 1US FAERS
85Blood triglycerides increasedFAERS: 1US FAERS
86Blood urea increasedFAERS: 1US FAERS
87Bone abscessFAERS: 1US FAERS
88BronchitisFAERS: 1US FAERS
89CachexiaFAERS: 1US FAERS
90Cardiac DeathFAERS: 1US FAERS
91CataractFAERS: 1US FAERS
92Cell marker increasedFAERS: 1US FAERS
93Chest PainFAERS: 1US FAERS
94CholecystitisFAERS: 1US FAERS
95ColitisFAERS: 1US FAERS
96CystitisFAERS: 1US FAERS
97DiplopiaFAERS: 1US FAERS
98DisorientationFAERS: 1US FAERS
99DiverticulumFAERS: 1US FAERS
100Drug prescribing errorFAERS: 1US FAERS
101DyspepsiaFAERS: 1US FAERS
102EczemaFAERS: 1US FAERS
103Electrolyte imbalanceFAERS: 1US FAERS
104EructationFAERS: 1US FAERS
105ErythemaFAERS: 1US FAERS
106Eye painFAERS: 1US FAERS
107Flank PainFAERS: 1US FAERS
108FlatulenceFAERS: 1US FAERS
109Food PoisoningFAERS: 1US FAERS
110Frustration tolerance decreasedFAERS: 1US FAERS
111Gastrointestinal infectionFAERS: 1US FAERS
112Genital rashFAERS: 1US FAERS
113GoutFAERS: 1US FAERS
114HypotensionFAERS: 1US FAERS
115Incorrect dose administeredFAERS: 1US FAERS
116InfectionFAERS: 1US FAERS
117Joint injuryFAERS: 1US FAERS
118Limb crushing injuryFAERS: 1US FAERS
119Limb injuryFAERS: 1US FAERS
120Liver AbscessFAERS: 1US FAERS
121LymphadenopathyFAERS: 1US FAERS
122MeaslesFAERS: 1US FAERS
123Memory impairmentFAERS: 1US FAERS
124Mouth swellingFAERS: 1US FAERS
125Multiple SclerosisFAERS: 1US FAERS
126Night sweatsFAERS: 1US FAERS
127Oral candidiasisFAERS: 1US FAERS
128ParanoiaFAERS: 1US FAERS
129Penile InfectionFAERS: 1US FAERS
130Peripheral swellingFAERS: 1US FAERS
131PolyuriaFAERS: 1US FAERS
132Renal Cell CarcinomaFAERS: 1US FAERS
133SciaticaFAERS: 1US FAERS
134Skin WrinklingFAERS: 1US FAERS
135Skin tightnessFAERS: 1US FAERS
136SyncopeFAERS: 1US FAERS
137TachycardiaFAERS: 1US FAERS
138Therapy non-responderFAERS: 1US FAERS
139TremorFAERS: 1US FAERS
140Urine alcohol test positiveFAERS: 1US FAERS
141VitiligoFAERS: 1US FAERS
142Vulvovaginal pruritusFAERS: 1US FAERS
143VulvovaginitisFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.